{"transactions":[{"id":2598824,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-08-19T00:00:22.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":2500,"price":44.51,"value":111275.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":17675,"source":{"system":"sec-edgar","filing":"0001437749-21-020457","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921020457/rdgdoc.xml","form_type":"4"}},{"id":2632593,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-17T00:00:24.000Z","date":"2021-07-15","kind":"sale","acquired":false,"shares":2500,"price":44.44,"value":111100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":20175,"source":{"system":"sec-edgar","filing":"0001437749-21-017103","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921017103/rdgdoc.xml","form_type":"4"}},{"id":2634444,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-15T00:02:38.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date."}],"balance_after":22675,"source":{"system":"sec-edgar","filing":"0001437749-21-016944","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921016944/rdgdoc.xml","form_type":"4"}},{"id":2664987,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-18T00:30:32.000Z","date":"2021-06-15","kind":"sale","acquired":false,"shares":2500,"price":38.35,"value":95875.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":17675,"source":{"system":"sec-edgar","filing":"0001437749-21-015121","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921015121/rdgdoc.xml","form_type":"4"}},{"id":2681837,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2021-06-05T00:30:54.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":10714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.12,"exercise_date":"2013-05-10","expiration_date":"2022-05-10","underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001437749-21-014195","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921014195/rdgdoc.xml","form_type":"4"}},{"id":2681836,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-05T00:30:54.000Z","date":"2021-04-21","kind":"exercise","acquired":true,"shares":10714,"price":1.12,"value":11999.68,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The number of securities reported in Column 5 is the number of securities beneficially owned as of June 4, 2021."}],"balance_after":20175,"source":{"system":"sec-edgar","filing":"0001437749-21-014195","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921014195/rdgdoc.xml","form_type":"4"}},{"id":2711286,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-18T00:00:50.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":2500,"price":29.06,"value":72650.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":9461,"source":{"system":"sec-edgar","filing":"0001437749-21-012572","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921012572/rdgdoc.xml","form_type":"4"}},{"id":2746265,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-20T00:54:51.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":512,"price":33.8,"value":17305.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":11961,"source":{"system":"sec-edgar","filing":"0001437749-21-009291","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921009291/rdgdoc.xml","form_type":"4"}},{"id":2746264,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-20T00:54:51.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":1988,"price":33.8,"value":67194.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":12473,"source":{"system":"sec-edgar","filing":"0001437749-21-009291","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921009291/rdgdoc.xml","form_type":"4"}},{"id":2784254,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-18T00:01:01.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1300,"price":37.32,"value":48516.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":14461,"source":{"system":"sec-edgar","filing":"0001437749-21-006376","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921006376/rdgdoc.xml","form_type":"4"}},{"id":2784253,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-03-18T00:01:01.000Z","date":"2021-03-15","kind":"sale","acquired":false,"shares":1200,"price":37.32,"value":44784.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":15761,"source":{"system":"sec-edgar","filing":"0001437749-21-006376","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921006376/rdgdoc.xml","form_type":"4"}},{"id":2856559,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-02-18T01:00:51.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2500,"price":45.67,"value":114175.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020."}],"balance_after":16961,"source":{"system":"sec-edgar","filing":"0001437749-21-003179","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921003179/rdgdoc.xml","form_type":"4"}},{"id":3011230,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-08T00:30:55.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date."}],"balance_after":19461,"source":{"system":"sec-edgar","filing":"0001437749-20-020870","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774920020870/rdgdoc.xml","form_type":"4"}},{"id":3384873,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2019-11-01T00:28:01.000Z","date":"2019-10-08","kind":"exercise","acquired":false,"shares":10714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.121,"exercise_date":"2011-02-11","expiration_date":"2021-02-11","underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001437749-19-021119","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919021119/rdgdoc.xml","form_type":"4"}},{"id":3384872,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T00:28:01.000Z","date":"2019-10-30","kind":"sale","acquired":false,"shares":6000,"price":17.87,"value":107220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."}],"balance_after":14461,"source":{"system":"sec-edgar","filing":"0001437749-19-021119","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919021119/rdgdoc.xml","form_type":"4"}},{"id":3384871,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-11-01T00:28:01.000Z","date":"2019-10-08","kind":"exercise","acquired":true,"shares":10714,"price":1.12,"value":11999.68,"ownership":{"direct":true},"balance_after":20461,"source":{"system":"sec-edgar","filing":"0001437749-19-021119","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919021119/rdgdoc.xml","form_type":"4"}},{"id":3401924,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-10-03T00:00:42.000Z","date":"2019-09-30","kind":"sale","acquired":false,"shares":6000,"price":16.01,"value":96060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."}],"balance_after":9747,"source":{"system":"sec-edgar","filing":"0001437749-19-019536","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919019536/rdgdoc.xml","form_type":"4"}},{"id":3426273,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-31T00:00:50.000Z","date":"2019-08-30","kind":"sale","acquired":false,"shares":6000,"price":20.07,"value":120420.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."}],"balance_after":15747,"source":{"system":"sec-edgar","filing":"0001437749-19-017732","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919017732/rdgdoc.xml","form_type":"4"}},{"id":3451411,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-08-02T00:00:48.000Z","date":"2019-07-30","kind":"sale","acquired":false,"shares":6000,"price":18.82,"value":112920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.32 to $19.16 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":21747,"source":{"system":"sec-edgar","filing":"0001437749-19-015234","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919015234/rdgdoc.xml","form_type":"4"}},{"id":3469559,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-04T00:01:00.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":6000,"price":17.33,"value":103980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.69 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":27747,"source":{"system":"sec-edgar","filing":"0001437749-19-013555","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919013555/rdgdoc.xml","form_type":"4"}},{"id":3506899,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-06-01T00:01:10.000Z","date":"2019-05-30","kind":"sale","acquired":false,"shares":6000,"price":17.5,"value":105000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."}],"balance_after":33747,"source":{"system":"sec-edgar","filing":"0001437749-19-011184","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919011184/rdgdoc.xml","form_type":"4"}},{"id":3543244,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-05-02T20:01:21.000Z","date":"2019-04-30","kind":"sale","acquired":false,"shares":6000,"price":17.19,"value":103140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2019."}],"balance_after":39747,"source":{"system":"sec-edgar","filing":"0001437749-19-008577","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774919008577/rdgdoc.xml","form_type":"4"}},{"id":3731507,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-14T21:02:29.000Z","date":"2018-12-13","kind":"sale","acquired":false,"shares":4000,"price":12.05,"value":48200.0,"ownership":{"direct":true},"balance_after":45747,"source":{"system":"sec-edgar","filing":"0001437749-18-022028","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918022028/rdgdoc.xml","form_type":"4"}},{"id":3894771,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2018-06-14T20:34:51.000Z","date":"2018-06-13","kind":"exercise","acquired":false,"shares":10714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.401,"exercise_date":"2011-02-05","expiration_date":"2020-02-04","underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001437749-18-011838","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918011838/rdgdoc.xml","form_type":"4"}},{"id":3894770,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Employee Stock Option","published_at":"2018-06-14T20:34:51.000Z","date":"2018-06-13","kind":"exercise","acquired":false,"shares":10714,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.261,"exercise_date":"2010-02-27","expiration_date":"2019-02-26","underlying":"Common Stock","underlying_shares":10714},"source":{"system":"sec-edgar","filing":"0001437749-18-011838","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918011838/rdgdoc.xml","form_type":"4"}},{"id":3894769,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T20:34:51.000Z","date":"2018-06-13","kind":"sale","acquired":false,"shares":10000,"price":11.25,"value":112500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.10 to $11.40, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":49474,"source":{"system":"sec-edgar","filing":"0001437749-18-011838","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918011838/rdgdoc.xml","form_type":"4"}},{"id":3894768,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T20:34:51.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":10714,"price":1.401,"value":15010.314,"ownership":{"direct":true},"balance_after":59747,"source":{"system":"sec-edgar","filing":"0001437749-18-011838","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918011838/rdgdoc.xml","form_type":"4"}},{"id":3894767,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-14T20:34:51.000Z","date":"2018-06-13","kind":"exercise","acquired":true,"shares":10714,"price":1.261,"value":13510.354,"ownership":{"direct":true},"balance_after":49033,"source":{"system":"sec-edgar","filing":"0001437749-18-011838","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774918011838/rdgdoc.xml","form_type":"4"}},{"id":4114958,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T02:32:05.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter."}],"balance_after":38319,"source":{"system":"sec-edgar","filing":"0001144204-18-000672","document":"tv482650_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420418000672/tv482650_4.xml","form_type":"4"}},{"id":4114957,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T02:32:05.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments."}],"balance_after":37381,"source":{"system":"sec-edgar","filing":"0001144204-18-000672","document":"tv482650_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420418000672/tv482650_4.xml","form_type":"4"}},{"id":4196229,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T20:05:49.000Z","date":"2017-10-03","kind":"grant","acquired":true,"shares":997,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter."}],"balance_after":27381,"source":{"system":"sec-edgar","filing":"0001144204-17-051157","document":"v476392_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417051157/v476392_4.xml","form_type":"4"}},{"id":4261281,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-07T20:03:05.000Z","date":"2017-07-06","kind":"grant","acquired":true,"shares":2354,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter."}],"balance_after":26384,"source":{"system":"sec-edgar","filing":"0001144204-17-036092","document":"v470491_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417036092/v470491_4.xml","form_type":"4"}},{"id":4359252,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-06T01:53:44.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":2679,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter."}],"balance_after":24030,"source":{"system":"sec-edgar","filing":"0001144204-17-019304","document":"v463690_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417019304/v463690_4.xml","form_type":"4"}},{"id":4460504,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-10T00:40:09.000Z","date":"2017-02-06","kind":"exercise","acquired":false,"shares":17857,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.12,"exercise_date":"2007-02-07","expiration_date":"2017-02-06","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0001144204-17-007171","document":"v458956_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417007171/v458956_4.xml","form_type":"4"}},{"id":4460503,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-10T00:40:09.000Z","date":"2017-02-06","kind":"exercise","acquired":true,"shares":17857,"price":1.12,"value":19999.84,"ownership":{"direct":true},"balance_after":21351,"source":{"system":"sec-edgar","filing":"0001144204-17-007171","document":"v458956_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417007171/v458956_4.xml","form_type":"4"}},{"id":4489192,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":136204,"kind":"person","name":"Hinson Andrew G","position":1,"cik":"0001389410","reported_name":"Hinson Andrew G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-19T00:35:34.000Z","date":"2017-01-13","kind":"grant","acquired":true,"shares":3494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of common stock were issued to the reporting person pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of receiving $5,625 of director fees for the quarter."}],"balance_after":3494,"source":{"system":"sec-edgar","filing":"0001144204-17-002793","document":"v456510_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000114420417002793/v456510_4.xml","form_type":"4"}}]}